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Do patients with suspected heart failure and
preserved left ventricular systolic function suffer from
“diastolic heart failure” or from misdiagnosis?
A prospective descriptive study
Lynn Caruana, Mark C Petrie, Andrew P Davie, John J V McMurray
Abstract
Objectives To characterise the clinical features of
patients with suspected heart failure but preserved left
ventricular systolic function to determine if they have
other potential causes for their symptoms rather than
being diagnosed with “diastolic heart failure.”
Design Prospective descriptive study.
Setting Outpatient based direct access
echocardiography service.
Participants 159 consecutive patients with suspected
heart failure referred by general practitioners.
Main outcome measures Symptoms (including
shortness of breath, ankle oedema, and paroxysmal
nocturnal dyspnoea) and history of coronary heart
disease and chronic pulmonary disease. Transthoracic
echocardiography, body mass index, pulmonary
function tests, and electrocardiography.
Results 109 of 159 participants had suspected heart
failure in the absence of left ventricular systolic
dysfunction, valvular heart disease, or atrial
fibrillation. Of these 109, 40 were either obese or very
obese, 54 had a reduction in forced expiratory volume
in 1 second to <70%, and 97 had a peak expiratory
flow rate <70% of normal. Thirty one patients had a
history of angina, 12 had had a myocardial infarction,
and seven had undergone a coronary artery bypass
graft. Only seven patients lacked a recognised
explanation for their symptoms.
Conclusions For most patients with a diagnosis of
heart failure but preserved left ventricular systolic
function there is an alternative explanation for their
symptoms—for example, obesity, lung disease, and
myocardial ischaemia—and the diagnosis of diastolic
heart failure is rarely needed. These alternative
diagnoses should be rigorously sought and managed
accordingly.
Introduction
With the recent wide availability of non›invasive assess›
ments of left ventricular function it has become appar›
ent that many patients diagnosed as having heart
failure have preserved left ventricular systolic func›
tion.1 2 It has been proposed that these patients have
abnormalities of ventricular filling in diastole, and the
term “diastolic heart failure” has been coined.1–3 It does,
however, seem likely that given the non›specificity of
the symptoms and signs used to diagnose heart failure
at least some of these patients may not have
abnormalities of diastolic ventricular function but
other causes of their symptoms altogether. We studied
consecutive patients who were referred with a diagno›
sis of suspected heart failure by general practitioners to
our direct access transthoracic echocardiography serv›
ice and were found to have preserved left ventricular
systolic function. We defined their clinical characteris›
tics and considered the alternative diagnoses of obesity,
respiratory disease, and ischaemic heart disease.
Methods
Patients—We studied patients with preserved left
ventricular systolic function who were referred with
suspected heart failure to an outpatient based direct
access cardiography service. Patients with left ventricu›
lar systolic dysfunction (according to qualitative
“eyeball” assessment, see below), valvular heart disease,
and atrial fibrillation were not studied further. The
study was approved by our local committee for medical
ethics. Each patient gave written informed consent.
Medical history, drug history, and symptoms—A full
clinical history was taken. Symptoms of shortness of
breath at rest or on exertion, paroxysmal nocturnal
dyspnoea, and ankle swelling were specifically
recorded. A past or current history of angina was also
specifically elicited. The severity of angina was graded
according to the Canadian Cardiovascular Society.4
Current medication was recorded.
Body mass index—Body mass index was calculated in
the usual way (weight (kg)/height (m)2). Participants
with a body mass index of less than 18.5 were defined
as underweight, 18.5›24.9 as normal weight, 25.0›29.9
as overweight, 30.0›39.9 as obese, and >40 as
extremely obese.5
Respiratory function—All patients had peak expira›
tory flow rate measured and had spirometry
performed—that is, forced expiratory volume in 1 sec›
ond (FEV1) and forced vital capacity.
Electrocardiography—A standard, resting 12 lead
electrocardiogram was recorded in each patient.
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Pathological Q waves were taken as evidence of previ›
ous myocardial infarction. ST/T changes, previous
myocardial infarction, or left bundle branch block were
considered to be consistent with a diagnosis of coron›
ary heart disease.
Transthoracic echocardiography—Each patient under›
went transthoracic echocardiography with an Acuson
128XP10c, with the patient recumbent in the left
lateral decubitus position. The same operator (LC)
performed all examinations. Qualitative assessment of
left ventricular systolic function was made by the “eye›
ball” technique, with two dimensional images.6 7 Quan›
titative assessment was made by measurement of
ejection fraction and fractional shortening by using M
mode echocardiography. Ejection fraction was also
measured using the Simpson’s biplane method.8 For
diastolic function the E:A ratio was measured as
described previously.1 9 Left ventricular hypertrophy
was assessed by M mode echocardiography.
Results
Patients—One hundred and fifty nine patients with sus›
pected heart failure were referred, and 34 had left ven›
tricular systolic dysfunction (18 out of 61 men (30%;
95% confidence interval 19% to 41%) and 16 out of 98
women (16%; 9% to 23%)). Ten patients had atrial
fibrillation, two patients had valvular disease, and four
patients had both atrial fibrillation and valvular heart
disease. One hundred and nine patients had suspected
heart failure in the absence of left ventricular systolic
function, valvular heart disease, or atrial fibrillation.
Details of these 109 patients is shown in table 1. In
keeping with findings of epidemiological studies, the
patients were elderly and usually female. Most patients
had been prescribed diuretics. Thirty three patients
were non›smokers, 29 were current smokers, and 47
were former smokers.
Dyspnoea and ankle swelling—Most men and women
reported dyspnoea on exertion, and about a quarter
reported either dyspnoea at rest or at night (table 1).
Men and women differed in their reporting of ankle
swelling, however, with twice as many women (80%)
complaining of this symptom.
Angina, myocardial infarction, and coronary artery
bypass graft—Thirty one (28%; 20% to 36%) patients
had a history of angina though only 11 (10%; 4% to
16%) currently had symptoms (seven were classified as
grade I, four as grade II). Twelve (11%; 5% to 17%)
patients gave a history of myocardial infarction, and
seven had undergone a coronary artery bypass graft. In
total, 33 (30%; 21% to 39%) patients either had a
history of angina or myocardial infarction or had
undergone a coronary artery bypass graft. Eight
patients had electrocardiographic evidence consistent
with coronary heart disease.
Body mass index—Of the 109 patients with suspected
heart failure in the absence of left ventricular systolic
dysfunction, valvular heart disease, or atrial fibrillation,
108 had their body mass index calculated. Details are
Table 1 Characteristics of patients referred for investigation of
suspected heart failure. Figures are number (percentage) of
patients unless stated otherwise
Men
(n=34)
Women
(n=75)
All
(n=109)
Mean (SD) age (years) 70 (13) 72 (11) 71 (11)
Mean (SD) heart rate (beats/min) 72 (18) 75 (15) 74 (16)
Mean (SD) systolic blood pressure
(mm Hg)
148 (19) 154 (24) 152 (23)
Mean (SD) diastolic blood pressure
(mm Hg)
84 (9) 85 (11) 85 (11)
Symptoms†
Short of breath at rest 11 (32) 16 (21) 2 (25)
Short of breath on exertion 29 (85) 71 (95) 100 (92)
Paroxysmal nocturnal dyspnoea 8 (24) 17 (23) 25 (23)
Ankle swelling 14 (41) 60 (80) 74 (68)
Concomitant conditions*:
Hypertension 16 (47) 35 (47) 51 (47)
Myocardial infarction 6 (18) 6 (8) 12 (11)
Angina 12 (35) 19 (25) 31 (28)
CABG 5 (15) 2 (3) 7 (6)
Pulmonary disease 9 (26) 17 (23) 25 (23)
Cigarette smoking
None 4 (12) 29 (39) 33 (30)
Current 12 (35) 17 (23) 29 (27)
Former 18 (53) 29 (39) 47 (43)
Medication†
Diuretics 28 (80) 57 (76) 85 (78)
â blockers 9 (26) 9 (12) 18 (17)
Nitrates 10 (30) 12 (16) 22 (20)
Calcium channel blockers 7 (21) 15 (20) 22 (20)
ACE inhibitors 2 (6) 4 (5) 6 (6)
Aspirin 14 (41) 19 (25) 33 (30)
Inhaled â2 agonists 7 (21) 15 (20) 22 (20)
Inhaled corticosteroids 4 (12) 4 (5) 8 (7)
Hypoglycaemic agents 2 (6) 4 (5) 6 (6)
Lipid lowering drugs 2 (6) 1 (1) 3 (3
NSAIDs 3 (9) 6 (8) 9 (8)
Digoxin 1 (3) 3 (4) 4 (4)
Warfarin 1 (3) 1 (1) 2 (2)
*Not mutually exclusive, patients can be in more than one category. CABG:
coronary artery bypass grafting; ACE: angiotensin converting enzyme; NSAID:
non›steroidal anti›inflammatory drug.
Table 2 Prevalence of abnormalities of body mass index, forced
expiratory volume in one second (FEV1), and electrocardiographic
abnormalities. Figures are number (percentage) of patients
Men Women All
Body mass index (kg/m2)
Underweight 0 1 (1.3) 1 (1)
Normal 8 (24) 15 (20) 23 (21)
Overweight 16 (47) 32 (43) 48 (44)
Obese 8 (24) 23 (31) 35 (32)
Extremely obese 2 (6) 3 (4) 5 (5)
FEV1 (%) of predicted
<50% 8 (24) 16 (21) 24 (22)
50›70% 14 (12) 16 (21) 30 (28)
71›90% 8 (24) 32 (43) 40 (37)
>91›100% 1 (3) 4 (5) 5 (5)
>100% 2 (6) 5 (7) 7 (6)
Electrocardiography
Normal 17 (50) 53 (71) 70 (64)
Abnormal 17 (50) 22 (29) 39 (36)
Abnormalities on electrocardiography*
Left bundle branch block 0 2 (3) 2 (2)
Left ventricular hypertrophy 2 (6) 1 (1) 3 (3)
Myocardial infarction 4 (12) 1 (1) 5 (5)
ST/T changes 4 (12) 9 (12) 13 (12)
Right bundle branch block 2 (6) 3 (4) 5 (5)
Paced 0 0 0
Bradycardia 2 (6) 1 (1) 3 (3)
Conduction abnormality 2 (6) 3 (4) 5 (5)
Right ventricular hypertrophy/right
axis deviation
0 (0) 2 (3) 2 (2)
*Categories not mutually exclusive.
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shown in table 2. Thirty five (32%; 23% to 41%) were
obese, and five (5%;1% to 9%) were extremely obese.
Respiratory function tests—Of 109 patients, 106 had
their respiratory function measured. Table 2 shows the
results of these measurements. Fifty four patients (50%;
41% to 59%) had FEV1 less than 70% of that predicted,
and 97 (92%; 86% to 98%) had a peak expiratory flow
rate <70% of normal.
Electrocardiography—Seventy (64%; 55% to 73%)
patients had a normal results on electrocardiography.
More men than women had abnormalities. These are
shown in table 2. As left bundle branch block, myocar›
dial infarction, and ST/T changes are typical findings
in coronary heart disease, 24% of men and 16% of
women had electrocardiographic evidence of possible
coronary heart disease. Taken in conjunction with evi›
dence from the clinical history (33 patients), eight
additional patients had either clinical or electrocardio›
graphic evidence of possible coronary heart disease—
that is, a total of 41 (38%; 29% to 47%) patients had
either clinical or electrocardiographic evidence of pos›
sible coronary heart disease.
Transthoracic echocardiography—Table 3 shows meas›
urements of left ventricular systolic function. By using
the E:A ratio, 67% (74% men and 64% women) had
“diastolic dysfunction.” Left ventricular hypertrophy
was detected in about one quarter of patients.
Assessment of the overlap of obesity, respiratory disease,
and cardiac abnormalities—Tables 4 and 5 show the
overlap between abnormalities of body mass index
(overweight, obesity, or extreme obesity), FEV1 (less
than 70% of predicted), cardiac structure (left ventricu›
lar hypertrophy), and evidence of coronary heart
disease (clinical or electrocardiographic). Table 4 com›
pares the overlap of obesity and angina with the pres›
ence of FEV1 less than 70% of predicted and left
ventricular hypertrophy. Table 5 differs from table 4 in
using abnormal body mass index (overweight, obese,
and extremely obese) in place of obesity and coronary
heart disease (history of angina (past or present), myo›
cardial infarction, coronary artery bypass graft, or ECG
changes consistent with coronary heart disease) in
place of angina. Of 109 patients for whom complete
data were available for all parameters, 106 were
included. Only nine (9%; 4% to 14%) patients were of
normal weight and had a FEV1 greater than 70% pre›
dicted. Of these, two had clinical or electrocardio›
graphic evidence of coronary heart disease. Conse›
quently, only seven patients (7%; 2% to 12%) had no
evidence of abnormalities of body mass index, respira›
tory disease, or coronary heart disease.
Discussion
Along with others, we have found that many patients
presenting with heart failure have preserved left
ventricular systolic function.1–3 10–15 While these patients
may have “diastolic dysfunction” it is also possible that
there are other explanations for their symptoms. The
problem about making a diagnosis of “diastolic” heart
failure non›invasively is that there is no agreement on
how this should be done, and different criteria for
diastolic dysfunction give enormously differing preva›
lences.2 16 One of the most commonly used criterion,
an E:A ratio of < 1, showed that most of our patients
with heart failure and preserved left ventricular systolic
function could be said to have diastolic dysfunction.
Rather than examine the vexed issue of how one
defines diastolic dysfunction with echocardiography
we have examined an alternative—that is, could there
be another explanation for these patients’ symptoms?
The most obvious alternative diagnoses are obesity,
respiratory disease, and myocardial ischaemia. We
found that the first two of these were common. A third
of patients were either obese or very obese. Half of the
patients had a considerable reduction in FEV1 (to 70%
or less) and 89% had a peak expiratory flow rate less
than or equal to 70% of normal. Remarkably, only nine
patients were of normal weight and had FEV1 greater
than 70% predicted. Though we sought to identify
myocardial ischaemia only by recording a history of
angina, 31 patients admitted to this symptom, 12 had a
history of myocardial infarction, and seven had
undergone coronary artery bypass surgery. Further›
more, at least 20 patients had electrocardiographic
changes consistent with myocardial ischaemia or
infarction. If we had undertaken exercise stress electro›
cardiography even more patients with myocardial
Table 3 Electrocardiographic parameters in patients referred
with suspected heart failure
Men Women All
Mean (SD) fractional shortening 29 (8) 30 (7) 30 (7)
Mean (SD) ejection fraction (M mode) 55 (12) 56 (10) 56 (11)
Mean (SD) ejection fraction
(Simpson’s biplane)
44 (11) 46 (9) 45 (10)
No (%) with left ventricular hypertrophy:
Mild 4 (12) 18 (24) 22 (20)
Moderate 2 (6) 3 (4) 5 (5)
Severe 1 (3) 0 (0) 1 (1)
No (%) with E:A ratio <1.0 20/27 (74) 45/70 (64) 65/97 (67)
Table 4 Overlap between FEV1, left ventricular hypertrophy,
angina, and obesity in 106/109 patients with complete data
FEV1 <70% FEV1 >70%
Obese Not obese Obese Not obese
Angina
Left ventricular hypertrophy:
Yes 1 2 1 1
No 6 13 1 4
No angina
Left ventricular hypertrophy:
Yes 4 11 4 3
No 11 22 7 15
Table 5 Overlap between FEV1, left ventricular hypertrophy,
coronary heart disease, and abnormal body mass index (BMI
>25) in 106/109 patients with complete data
FEV1 <70% FEV1 >70%
Abnormal BMI Normal BMI Abnormal BMI Normal BMI
Coronary heart disease*
Left ventricular hypertrophy:
Yes 2 1 6 0
No 12 6 10 2
No coronary heart disease
Left ventricular hypertrophy:
Yes 6 2 8 2
No 17 7 21 4
*History of angina (past or present), myocardial infarction or CABG, or ECG
changes typical of coronary heart disease.
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ischaemia would probably have been identified. Of the
nine patients with normal weight and FEV1 greater
than 70%, a further two had clinical or electrocardio›
graphic evidence of coronary heart disease. In other
words, only seven patients in this study with a diagno›
sis of heart failure but preserved left ventricular systo›
lic function lacked a recognised explanation for their
symptoms—that is, a diagnosis of diastolic heart failure
was inappropriate. The important message for
clinicians is that an echocardiogram suggesting diasto›
lic dysfunction on the basis of an abnormal E:A ratio is
not diagnostic and represents insufficient investigation.
We clearly need to improve differentiation of
breathlessness due to isolated diastolic dysfunction
from that with other causes. It would seem that a rigor›
ous search for non›cardiac causes of breathlessness
must be pursued, with pulmonary function testing,
calculation of body mass index, resting and exercise
electrocardiography, and, probably, chest radiography.
Even if these other causes are excluded it may still be
difficult to be sure that a patient’s breathlessness is
definitely cardiac in origin. One possibility is that
measurement of plasma natriuretic peptide concentra›
tions might further refine the diagnostic process. It
might be expected that increased left ventricular mass,
wall stress, or filling pressures would increase secretion
of atrial or brain natriuretic peptides. This possibility
needs to be tested further.
Of course, it is also possible that patients may have
more than one cause of their dyspnoea. This real
diagnostic dilemma reinforces the need for better means
of determining whether or not there really is a
non›systolic cardiac contribution in such cases. We
believe that improved patient care should result from
recognition of the true cause of a patient’s breathlessness
as appropriate management of the correct alternative
diagnoses can improve presenting symptoms.
In summary, we have shown that in most patients
with a diagnosis of heart failure but preserved left ven›
tricular systolic function there are alternative explana›
tions for their symptoms—for example, obesity, lung
disease, and myocardial ischaemia. For that reason the
diagnosis of diastolic heart failure is probably unneces›
sary, even though a high proportion of these patients
will have echocardiographic evidence of diastolic
dysfunction.16
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Science commentary: Echocardiography
Echocardiography uses very high frequency sound
waves (ultrasound), which are inaudible to human ears.
Sound waves are forms of pressure wave; they can travel
through any medium. In echocardiography these waves
are generated and detected by means of a piezoelectric
crystal contained within a transducer.1 A simple
mechanical scanner comprises a single crystal that is
oscillated by a small motor, while the newer (“phased
array”) systems comprise multiple crystal elements that
are pulsed in a rapid and controlled sequence. In cardiac
imaging the ultrasound beam arises from a small source
and is directed, in a pyramidal sector, across the heart.
In the body, echoes are generated when ultrasound
waves reach tissue, where the acoustic properties (den›
What is already known on this topic
Patients with suspected heart failure but preserved left ventricular
systolic function are commonly said to have “diastolic heart
failure”
What this study adds
Most of these patients have an alternative explanation for their
symptoms, such as obesity, pulmonary disease, and myocardial
ischaemia
Complete investigation of these patients requires more than an
echocardiogram
Improved patient care should result from recognition of the true
cause of a patient’s symptoms as there are appropriate management
strategies for these alternative diagnoses; this is preferable to ascribing
symptoms to diastolic heart failure for which there is no evidence
based treatment
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sities) change, and are then reflected back. This usually
happens at organ boundaries, tissue interfaces, and
cellular boundaries. The transducer detects echoes
before being converted into electrical signals that are
represented on an oscilloscopic display. Dense
structures, such as the pericardium and calcified valves,
appear bright (white), whereas blood filled cavities
(atria, ventricles) are almost echo free (black). Multiple
reflections occur when the ultrasound beam reaches an
object with greatly differing transmission characteris›
tics from those of the surrounding tissues. For
example, prosthetic valves may produce multiple
parallel echoes and associated “ghost” images.
Ultrasound waves are sinusoidal fluctuations in pres›
sure; the size of each pressure wave is termed the ampli›
tude, the distance between the two waves is the
wavelength, and the number of waves per second is the
frequency. For medical applications, the frequency of
ultrasound tends to lie within the range of 2›20 million
cycles per second (MHz), and echocardiography sits at
the lower end of this spectrum (2.5›10 MHz). During
transmission through tissues, energy is lost due to
absorption and scattering, and thus the reflected energy
of the echo is invariably lower than the original
ultrasound. Higher frequency waves may provide better
image quality, although tissue penetration is not as good.
Complete echocardiographic examination entails
the use of three different imaging modes: two
dimensional, M mode (a graph of motion against time),
and Doppler studies. Two dimensional imaging
enables the operator to make a subjective assessment
of the size of the cardiac chamber and ventricular
function and allows detailed assessment (morphology/
mobility) of valvar structures. M mode is useful for
making accurate measures of chamber size and wall
thickness at specific points in the cardiac cycle. Doppler
techniques are divided into three types: pulsed wave,
continuous wave, and colour flow. Pulsed wave and
continuous wave Dopplers are used to detect the direc›
tion and velocity of blood flow across heart valves (this
allows calculation of valve gradients). Colour flow
imaging provides a pictorial coloured representation
of blood flow in the heart and across valves. This is a
useful screening tool as the direction of blood flow and
the presence of turbulence can be identified. It is
particularly useful for detecting evidence of regurgita›
tion across valves or abnormal patterns of blood flow
(for example, in a ventricular septal defect).
Abi Berger science editor, BMJ
1 Cheeseman MG, Leech G, Chambers J, Monaghan MJ, Nihoyannopoulos
P. Central role of echocardiography in the diagnosis and assessment of
heart failure. Heart 1998;80(suppl 1):1›5.
Not such an angel?
Easter Monday was a relaxing day, working in the garden and
greenhouse after a weekend on duty. All went well until late
afternoon when I stopped for a cup of tea. I suddenly realised
that my vision was blurred. I closed one eye, then the other, and it
quickly became clear that my left eye was at fault. Calmly I went in
and looked in the mirror—only to find that my
left pupil was grossly dilated, the right one being
normal and reacting. Then I became less calm.
Thoughts of vitreous haemorrhage, Homer’s
syndrome, retinal vein thrombosis, etc, went
through my mind. Nothing for it but to contact
our out of hours cooperative, where one of my
partners happened to be on duty at a surgery
session. At least this wasn’t the middle of the
night.
Having checked my fundus, visual fields, blood
pressure, etc, and found all normal, he was not
sure what was wrong. Reassured by the normal
fundus I began to wonder if I had been in
contact with something in the garden. The next
step was down to the district general hospital, some 23 miles
away, to see the ophthalmic senior house officer. He checked the
eye thoroughly with the slit lamp, although by now the vision was
beginning to improve, and the pupil was showing some reaction
to light. He contacted the consultant, who came and again
examined the eye. He was not sure what was going on but
proposed a review in the eye clinic if it did not improve. The
suggestion that some chemical from the garden was responsible
was regarded as a possibility, although he was more concerned
that mydriatics from my medical bag may have somehow found
their way into my eye.
Next day in surgery, my partners were relieved to find that my
vision was better, so I was able to drive and work. The left pupil
was slightly smaller, but remained larger than the right one.
After morning surgery, while we were all busy with prescriptions
and telephone queries, our registrar used the internet to search for
“unilateral dilated pupil.” We were both surprised at how many
entries there were, but on scanning through them I noticed
mention of “angel trumpet”—a paper in German without an
abstract1. Knowing that I had two of these plants in the greenhouse
and may have brushed against them, we looked for similar papers.
We found a further paper on angel trumpet referring to its
hallucinogenic properties and the danger of ingesting any part of
it.2 Apparently a group of youths died in the
summer of 1997 after ingesting flowers from the
plant. Analysis showed scopolamine among the
poisons identified, almost certainly explaining my
experience. This paper was also in German, but
fortunately had an English abstract. Further
searches revealed a paper confirming the
presence of scopolamine in this plant.3 Atropine
was looked for, but not found.
By that evening the pupil was back to normal,
but I shall be treating my datura (angel trumpet)
with great care in future. These plants are widely
available. Perhaps they should carry a health
warning.
John Merrick general practitioner, and
Stephen Barnett general practitioner registrar, Street, Somerset
1 Geiss R, Mullges W. Unilateral mydriasis after cutting back angel trumpet. Dtsch
Med Wochenschr 1999;124(48):1456.
2 Neiss C, Schnabel A, Kauert G. Angel trumpet: a poisonous garden plant as a
new addictive drug? Dtsch Med Wochenschr 1999;124(48):1444›7.
3 Smith EA, Meloan CE, Pickell JA, Oehme FW. Scopolamine poisoning from
home made ‘moon flower’ wine. J Anal Toxicol 1991;15(4):216›9.
We welcome articles of up to 600 words on topics such as A
memorable patient, A paper that changed my practice,My most
unfortunate mistake, or any other piece conveying instruction,
pathos, or humour. If possible the article should be supplied on a
disk. Permission is needed from the patient or a relative if an
identifiable patient is referred to. We also welcome contributions
for “Endpieces,” consisting of quotations of up to 80 words (but
most are considerably shorter) from any source, ancient or
modern, which have appealed to the reader.
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